Recent News

• 03.03.2025 - New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
• 03.03.2025 - New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
• 02.27.2025 - Q4 2024 Personalis Earnings Conference Call
• 02.27.2025 - Q4 2024 Personalis Earnings Conference Call
• 02.27.2025 - Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.27.2025 - Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.18.2025 - Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference
• 02.18.2025 - Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference
• 02.13.2025 - Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results
• 02.13.2025 - Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

Recent Filings

• 02.27.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2025 - 8-K Current report
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - S-3 Registration statement under Securities Act of 1933
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.10.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2025 - 4 Statement of changes in beneficial ownership of securities